{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:06:52Z","timestamp":1789751212112,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0551700"],"award-info":[{"award-number":["2025ZD0551700"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0551701"],"award-info":[{"award-number":["2025ZD0551701"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinthera.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:24:29Z","timestamp":1787862269000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Readily Available Prognostic Biomarkers of Lung Cancer Treated With Immune Checkpoint Inhibitors in Northeast China"],"prefix":"10.1016","author":[{"given":"Jianmei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuening","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.07.009_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0002","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1097\/JS9.0000000000002183","article-title":"Evaluating pathological complete response as an surrogate endpoint for long-term survival in patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"111","author":"Li","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0003","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41392-025-02435-0","article-title":"CD8+ TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patients","volume":"10","author":"Lin","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0004","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ccell.2025.07.005","article-title":"Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer","volume":"43","author":"Ghisoni","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0005","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","article-title":"Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours","volume":"24","author":"Holder","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0006","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41587-021-01070-8","article-title":"Improved prediction of immune checkpoint blockade efficacy across multiple cancer types","volume":"40","author":"Chowell","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0007","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-023-02660-6","article-title":"Association between pathologic response and survival after neoadjuvant therapy in lung cancer","volume":"30","author":"Deutsch","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0008","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s43018-024-00772-7","article-title":"LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features","volume":"5","author":"Chang","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010644","article-title":"Chrono-immunotherapy as a low-hanging fruit for cancer treatment? A call for pragmatic randomized clinical trials","volume":"13","author":"\u00d6zdemir","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0010","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/07853890.2023.2181983","article-title":"Prognostic and clinicopathological significance of systemic immune-inflammation index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis","volume":"55","author":"Wang","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0011","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1097\/JS9.0000000000002996","article-title":"Extensive study on the associations of 12 composite inflammatory indices with colorectal cancer risk and mortality: a cross-sectional analysis of NHANES 2001\u20132020","volume":"111","author":"Zhou","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1605032","article-title":"Association between prognostic nutritional index and all-cause mortality in critically ill patients with ventilator-associated pneumonia: a retrospective study based on MIMIC-IV database","volume":"12","author":"Ji","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0013","article-title":"Integrated machine learning and population attributable fraction analysis of systemic inflammatory indices for mortality risk prediction in diabetes and prediabetes","volume":"57","author":"Zhang","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0014","article-title":"Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/cancers12010152","article-title":"Prediction of postoperative clinical outcomes in resected stage I non-small cell lung cancer focusing on the preoperative Glasgow prognostic score","volume":"12","author":"Lindenmann","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1550490","article-title":"Nutritional status and systemic inflammation in COPD: prognostic value of the advanced lung cancer inflammation index","volume":"12","author":"Yao","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0017","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1186\/s12889-024-19727-9","article-title":"Combined influence of nutritional and inflammatory status and breast cancer: findings from the NHANES","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0018","first-page":"899","article-title":"Construction of a nomogram model for the prognosis of advanced non-small cell lung cancer patients treated with microwave ablation combined with immunotherapy based on inflammatory and nutritional indicators","volume":"37","author":"Li","year":"2024","journal-title":"J Math Med"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/JN9.0000000000000038","article-title":"Baseline and early dynamic changes in inflammatory and nutritional status can predict survival in patients with advanced biliary tract carcinoma receiving immunotherapy: a retrospective cohort study","volume":"9","author":"Shen","year":"2024","journal-title":"J Nutr Oncol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0020","article-title":"Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study","volume":"46","author":"Mirallas","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0021","first-page":"2495","article-title":"New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)","volume":"36","author":"Watanabe","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0022","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41467-025-55847-5","article-title":"Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer","volume":"16","author":"Captier","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu2151","article-title":"Single-cell multimodal analysis reveals tumor microenvironment predictive of treatment response in non-small cell lung cancer","volume":"11","author":"Zheng","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0024","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/2767-9764.CRC-25-0157","article-title":"Chemoimmunotherapy outcomes and prognostic factors in patients with advanced, low PD-L1-expressing non-small cell lung cancer","volume":"5","author":"Hata","year":"2025","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jtho.2024.09.1381","article-title":"Durvalumab with or without tremelimumab in combination with chemotherapy in first-line metastatic NSCLC: five-year overall survival outcomes from the phase 3 POSEIDON trial","volume":"20","author":"Peters","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0026","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S1470-2045(25)00198-6","article-title":"Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial","volume":"26","author":"Zhou","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0027","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.11181","article-title":"Assessment of tumor mutational burden and outcomes in patients with diverse advanced cancers treated with immunotherapy","volume":"6","author":"Aggarwal","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0029","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41587-021-01070-8","article-title":"Improved prediction of immune checkpoint blockade efficacy across multiple cancer types","volume":"40","author":"Chowell","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41698-022-00267-7","article-title":"Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade","volume":"6","author":"Yoo","year":"2022","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0031","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1186\/s12889-024-19727-9","article-title":"Combined influence of nutritional and inflammatory status and breast cancer: findings from the NHANES","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0032","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.3390\/cancers13225772","article-title":"Nutritional status as a predictive biomarker for immunotherapy outcomes in advanced head and neck cancer","volume":"13","author":"Guller","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0033","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/cancers15041076","article-title":"Effect of cancer-related cachexia and associated changes in nutritional status, inflammatory status, and muscle mass on immunotherapy efficacy and survival in patients with advanced non-small cell lung cancer","volume":"15","author":"Madeddu","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1591508","article-title":"Nutritional and immune-inflammatory scoring system for predicting outcomes in newly diagnosed diffuse large B-cell lymphoma patients","volume":"12","author":"Peng","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0035","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/1759-7714.15401","article-title":"The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors","volume":"15","author":"Horstman","year":"2024","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0036","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/nu15163604","article-title":"Association between pre-treatment biological indicators and compliance to neoadjuvant\/perioperative chemotherapy in operable gastric cancer","volume":"15","author":"Monti","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0037","article-title":"Immunotherapy of small cell lung cancer based on prognostic nutritional index","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0038","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/07853890.2023.2181983","article-title":"Prognostic and clinicopathological significance of systemic immune-inflammation index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis","volume":"55","author":"Wang","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0039","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.clnu.2019.05.009","article-title":"Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition inflammation markers of outcome in patients with gastric cancer","volume":"39","author":"Okugawa","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0040","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.2147\/JIR.S526429","article-title":"Development and validation of a new immune-inflammatory-nutritional score to predict pathological complete response in triple-negative breast cancer undergoing neoadjuvant chemotherapy: a two-center study","volume":"18","author":"Wang","year":"2025","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.clinthera.2026.07.009_bib0041","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41587-021-01070-8","article-title":"Improved prediction of immune checkpoint blockade efficacy across multiple cancer types","volume":"40","author":"Chowell","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.clinthera.2026.07.009_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100254","article-title":"Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer","volume":"6","author":"Mountzios","year":"2021","journal-title":"ESMO Open"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:19:08Z","timestamp":1789748348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826002705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S0149291826002705"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Readily Available Prognostic Biomarkers of Lung Cancer Treated With Immune Checkpoint Inhibitors in Northeast China","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}